Videos

Catalent CEO Talks Gene Therapy Trends

Catalent CEO Talks Gene Therapy Trends

A Q&A with John Chiminski

06.14.19
At BIO 2019 Contract Pharma had a chance to discuss gene therapy trends and Catalent's recent acquisition of Paragon Bioservices with CEO John Chiminski.
Related Searches:
Suggested For You
Catalent Launches OneBio Suite Catalent Launches OneBio Suite
Catalent Expands Patient-Centric Dose Form Mfg. Capabilities Catalent Expands Patient-Centric Dose Form Mfg. Capabilities
Catalent Invests $14M at Germany Softgel Facility Catalent Invests $14M at Germany Softgel Facility
Paragon to Build Second GMP Mfg. Facility Paragon to Build Second GMP Mfg. Facility
Catalent to Acquire Paragon for $1.2B Catalent to Acquire Paragon for $1.2B
Catalent Inaugurates Second Shanghai Facility Catalent Inaugurates Second Shanghai Facility
Solid Dose Processing & Packaging Trends Solid Dose Processing & Packaging Trends
Meeting Bioprocessing Mfg. Capacity Demands Meeting Bioprocessing Mfg. Capacity Demands
Catalent Expands OptiMelt Capabilities at Somerset CoE Catalent Expands OptiMelt Capabilities at Somerset CoE
Solid Dose Packaging Solid Dose Packaging
Early Development Trends Early Development Trends
Catalent Enters Clinical Supply Partnership with Adial Catalent Enters Clinical Supply Partnership with Adial
Catalent Appoints President & COO Catalent Appoints President & COO
Reed-Lane Makes the Move into Cold Chain Market Reed-Lane Makes the Move into Cold Chain Market
Reed-Lane Makes the Move into Cold Chain Market Reed-Lane Makes the Move into Cold Chain Market

Related Breaking News

    Loading, Please Wait..